Eventide Asset Management
Investment Details
Investor Type
Private Investment Firm
Asset Class Focus
Private Equity, Venture Capital, Fixed Income (Debt and Bonds), Hedge Funds, Real Estate, Commodities, Crypto, Infrastructure, Distressed and Special Situations, ESG and Impact Investing
Stage Focus
Seed, Early Stage, Series A, Series B, Growth, Late Stage, Pre-IPO, Buyout, Turnaround, Distressed
Geographical Focus
United States, United Kingdom, Canada, Germany, Japan, Australia, China, India, Brazil, France, Italy, Denmark, Switzerland, Spain, Mexico, South Korea, Netherlands, Sweden, Belgium, Norway
Industries Focus
- Financial Services
- Technology
- Healthcare
- Energy
- Consumer Goods
- Industrials
- Real Estate
- Materials
- Telecommunications
- Utilities
- Media
- Retail
- Transportation
- Consumer Services
- Biotechnology
Investment Size:
1,000,000 to 50,000,000 USD
Investor Details Founded: 2008
Eventide Asset Management, founded in 2008, is a Boston-based investment firm dedicated to 'investing that makes the world rejoice®.' The firm specializes in values-based investing, focusing on companies that create compelling value for the global common good. Eventide offers a range of investment solutions, including mutual funds, ETFs, separately managed accounts, and private equity investments, with a particular emphasis on healthcare and biotechnology sectors. The firm's proprietary Business 360® framework combines data and human discernment to evaluate companies' products and practices, ensuring alignment with their investment philosophy. Eventide's portfolio includes investments in various industries such as healthcare, biotechnology, technology, and consumer goods, with a geographical focus on the United States and select international markets. The firm is led by CEO Robin John and Co-Chief Investment Officer Dolores Bamford, with a team of experienced professionals committed to delivering high-performance investments that align with their values-based approach.
Requirements
- Alignment with Eventide's values-based investment philosophy
- Focus on companies with strong growth potential and innovative solutions
- Commitment to creating value for the global common good
Contact
[Official Website Hidden]
[HQ Location Hidden]
[Email Hidden]
[Contact Number Hidden]
Portfolio Companies
- Ovid Therapeutics
- Beta Bionics
- Celldex Therapeutics
- PreciseDx
- Ironwood Pharmaceuticals
- Old Dominion Freight Line
- Trane Technologies
- Roper Technologies
Mentioned In
-
$9.95
-
$9.95
-
$14.95
-
$39.95
-
$19.95
-
$24.95
-
$19.95
-
$24.95
-
$99.00
-
$299.00
Claim this Investor
Are you an official representative of Eventide Asset Management?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim